Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ASP Isotopes (ASPI) Return on Sales (2023 - 2025)

ASP Isotopes has reported Return on Sales over the past 3 years, most recently at 3.8% for Q4 2025.

  • On a quarterly basis, Return on Sales rose 404.0% to 3.8% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.7%, a 116.0% increase, with the full-year FY2025 number at 6.7%, up 116.0% from a year prior.
  • Return on Sales reached 3.8% in Q4 2025 per ASPI's latest filing, down from 2.64% in the prior quarter.
  • The five-year high for Return on Sales was 2.64% in Q3 2025, with the low at 62.72% in Q2 2025.
  • The 3-year median for Return on Sales is 7.85% (2024), against an average of 13.12%.
  • The largest YoY upside for Return on Sales was 413bps in 2025 against a maximum downside of -5403bps in 2025.
  • Tracing ASPI's Return on Sales over 3 years: stood at 9.63% in 2023, then grew by 19bps to 7.85% in 2024, then soared by 52bps to 3.8% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 3.8%, 2.64%, and 62.72% for Q4 2025, Q3 2025, and Q2 2025 respectively.